ClinicalTrials.Veeva

Menu

Evaluation 2% Chlorhexidine Gluconate

M

Medline Industries

Status and phase

Completed
Phase 2

Conditions

Skin Coverage

Treatments

Drug: 2% CHG

Study type

Interventional

Funder types

Industry

Identifiers

NCT03326726
R16-034

Details and patient eligibility

About

Medline 2% CHG cloth (Active) - A single cloth from the pack was used per treatment area. The investigational test article was applied topically by vigorously scrubbing the skin in a back and forth motion for three minutes (and halfway through the 3-minute application time, the cloth was turned over) over the treatment area (7" x 10" of the subject's back), and the skin was allowed to air dry.

Enrollment

30 patients

Sex

Male

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Healthy males of at least 18 years of age having skin within 6 inches of the test regions that were free of tattoos, dermatoses, abrasions, cuts, lesions or other skin disorders, with no history of sensitivity to CHG and were able to lie prone for up to 30 minutes.

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Chlorhexidine Gluconate
Experimental group
Description:
2% CHG
Treatment:
Drug: 2% CHG

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems